Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06902714 · ClinicalTrials.gov registry record · Phase 3
Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty
A Phase 3 study, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
NCT06902714 is a Phase 3 study that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants.
The verdict
NCT06902714, a Phase 3 study, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid
Interventions
- DRUG Placebo
- DRUG oral tranexamic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-04-20 |
| Est. Completion | 2030-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06902714
The ClinicalTrials.gov registry entry for NCT06902714 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06902714 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06902714 about?
NCT06902714 is a clinical study titled "Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty". The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid
What is the current status of trial NCT06902714?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2026-04-20. Estimated completion is 2030-12.
What interventions are being tested in trial NCT06902714?
The interventions under investigation include: Placebo (DRUG), oral tranexamic acid (DRUG).
Who is sponsoring clinical trial NCT06902714?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.